TY - JOUR
T1 - Potential neuroprotective effects of acamprosate
AU - Koob, George F.
AU - Mason, Barbara J.
AU - De Witte, Philippe
AU - Littleton, John
AU - Siggins, George R.
PY - 2002
Y1 - 2002
N2 - This article represents the proceedings of a symposium at the 2001 RSA Meeting in Montreal, Canada. The organizers were Barbara J. Mason and George F. Koob. Anita M. Goodman served as chair. The presentations were (1) Acamprosate inhibits alcohol withdrawal-induced neurotoxicity in organotypic hippocampal cultures, by John Littleton; (2) Acamprosate alteration of NMDA receptor-dependent synaptic transmission and synaptic plasticity, by George R. Siggins; (3) Acamprosate and glutamate during ethanol withdrawal, by Philippe De Witte; (4) Clinical evidence of protective CNS effects of acamprosate in alcohol-dependent individuals, by Barbara J. Mason.
AB - This article represents the proceedings of a symposium at the 2001 RSA Meeting in Montreal, Canada. The organizers were Barbara J. Mason and George F. Koob. Anita M. Goodman served as chair. The presentations were (1) Acamprosate inhibits alcohol withdrawal-induced neurotoxicity in organotypic hippocampal cultures, by John Littleton; (2) Acamprosate alteration of NMDA receptor-dependent synaptic transmission and synaptic plasticity, by George R. Siggins; (3) Acamprosate and glutamate during ethanol withdrawal, by Philippe De Witte; (4) Clinical evidence of protective CNS effects of acamprosate in alcohol-dependent individuals, by Barbara J. Mason.
KW - Acamprosate
KW - Alcoholism
KW - Glutamate
KW - Neuroprotective
UR - http://www.scopus.com/inward/record.url?scp=0036124030&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036124030&partnerID=8YFLogxK
U2 - 10.1111/j.1530-0277.2002.tb02578.x
DO - 10.1111/j.1530-0277.2002.tb02578.x
M3 - Article
C2 - 11981137
AN - SCOPUS:0036124030
SN - 0145-6008
VL - 26
SP - 586
EP - 592
JO - Alcoholism: Clinical and Experimental Research
JF - Alcoholism: Clinical and Experimental Research
IS - 4
ER -
